Bridgeway Capital Management’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-90,000
| Closed | -$53.2K | – | 1182 |
|
|
2024
Q4 | $53.2K | Sell |
90,000
-25,000
| -22% | -$14.8K | ﹤0.01% | 1152 |
|
|
2024
Q3 | $202K | Buy |
115,000
+25,000
| +28% | +$44K | ﹤0.01% | 1063 |
|
|
2024
Q2 | $123K | Hold |
90,000
| – | – | ﹤0.01% | 1142 |
|
|
2024
Q1 | $310K | Sell |
90,000
-10,000
| -10% | -$34.4K | 0.01% | 1032 |
|
|
2023
Q4 | $246K | Sell |
100,000
-12,000
| -11% | -$29.5K | 0.01% | 1093 |
|
|
2023
Q3 | $190K | Buy |
112,000
+35,000
| +45% | +$59.5K | ﹤0.01% | 1111 |
|
|
2023
Q2 | $231K | Buy |
77,000
+55,000
| +250% | +$165K | 0.01% | 1100 |
|
|
2023
Q1 | $59K | Hold |
22,000
| – | – | ﹤0.01% | 1296 |
|
|
2022
Q4 | $182K | Hold |
22,000
| – | – | ﹤0.01% | 1108 |
|
|
2022
Q3 | $169K | Buy |
+22,000
| New | +$169K | ﹤0.01% | 1167 |
|